Exact Sciences

A heartfelt thank-you to our amazing Exact Sciences teammates! We deeply appreciate the positivity, energy, and dedication you bring to work every day. Wishing you a joyful and Happy Thanksgiving!

We’re sharing data at #SABCS25 showcasing our commitment to advancing breast cancer care and providing actionable insights for patients and their health care providers: http://spr.ly/60417Wij3

We have some award-winning dogs! We’re pleased to share that our “Pick Up Your Poop” campaign, in collaboration with F Cancer, won an Anthem Award for its efforts to raise awareness and inspire action against colorectal cancer. See the PSA below and remember to listen to your furry friend and get screened. See more: http://spr.ly/60407WEKm The Anthem Awards

Today, we announced that Exact Sciences has agreed to be acquired by Abbott, one of the world’s most respected healthcare companies. The combination is expected to close in the second quarter of 2026, pending regulatory approval and Exact Sciences’ shareholder approval. For more than 16 years, we’ve worked to transform cancer diagnostics and improve patient lives. This next chapter will allow us to bring earlier answers to more people around the world. We’re proud of what our team has built — a purpose-driven company, innovative science, and life-changing tests that have already helped more than 25 million people. That mission will continue, stronger than ever, as part of Abbott. To our Exact Sciences team: thank you for your commitment, your compassion, and your belief in what we do every day. Read more: http://spr.ly/60447iu0p #HealthcareInnovation #CancerDiagnostics #MissionDriven

Colorectal cancer is on the rise in adults under the age of 50, which is why screening starting at the age of 45 is more important than ever. Tim was 46 when his doctor mentioned that the guideline-recommended age to screen had lowered from 50 to 45. He thought he had no reason to screen but agreed to complete a Cologuard® test. He was shocked when the result was positive, and a follow-up colonoscopy revealed stage III colon cancer. Tim’s colon cancer was more treatable because of when he took action. Had he waited until age 50, he might not be living cancer-free today. Keep watching via Katie Couric Media: http://spr.ly/60467ewXM

Genetic counselors play a vital role in our health care system, operating behind the scenes to analyze a person’s DNA and deliver answers that are easy to understand. We’re grateful for our team of genetic counselors across Exact Sciences and PreventionGenetics. Thank you for all you do! #GeneticCounselorAppreciationDay

Veterans are more likely to have conditions that can lead to liver disease, making liver cancer a significant concern among this group. A recent study that enrolled more than 3,000 participants, including veterans, found that the Oncoguard® Liver test delivered superior early detection of liver cancer through blood-based surveillance. These findings underscore the potential to transform liver cancer surveillance for at-risk populations, like veterans. #VeteransDay Find out more: http://spr.ly/60407TVAi

Exciting news! With the Hart-Scott-Rodino Act waiting period complete, our license agreement with Freenome moves forward. Together, we’re working toward a future where even more people can detect cancer earlier. Read more: http://spr.ly/60447Tr4i

Results from our landmark ALTUS study demonstrate superior early detection of liver cancer with the Oncoguard® Liver blood test. Compared to standard of care options, the Oncoguard Liver test delivered seven times greater sensitivity for very early-stage hepatocellular carcinoma (HCC), the most common form of liver cancer. These findings will be presented at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® this week. Read more: http://spr.ly/60407PSf6

Today, we announced our third quarter 2025 earnings results. For more information, see our press release here: http://spr.ly/60477KcHd